ABOUT US
MAKING OUR PRESENCE FELT WORLDWIDE
AFYX is making a meaningful impact across 46 global markets, both directly and through our valued partners.
We deliver innovative solutions for:
- Head & Neck Cancer
- Labor Induction
- Cluster Headaches
- Pain & Addiction
Our technologies are improving lives every day by addressing critical medical needs with precision and purpose.
MERGING
DECADES OF
TECHNOLOGY
AFYX is a Biopharmaceutical company with a focus on reformulation and repurposing of pharmaceuticals.
2014: AFYX THERAPEUTICS
Development of a proprietary patented patch technology that sticks to wet surfaces
2015: LIONHEART PHARMACEUTICALS
Treatment of chronic and intermittent cluster headache.
2017: INPHENA PAIN & CANCER
Research, development and sales of repurposed existing pharmaceutical.
2024: MERGE: AFYX THERAPEUTICS
A history of Reversed Innovation. Biopharmaceutical company established through a merger of the above companies.
AFYX THERAPEUTICS HQ
Slotsmarken 11, 1.tv.
DK-2970 Hørsholm
Denmark
VAT: 38793594
Phone: +45 7174 7174
info@afyxtx.com
AFYX NORWAY
Gaustadalléen 21
NO-0349 Oslo
Norway
VAT: 922 558 221
Phone: +47 2396 7174